X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/kaleido-a-flagship-microbiome-startup-lays-off-staff-cash-runway-shrinking-report
https://www.globenewswire.com/news-release/2022/01/21/2371028/0/en/Kaleido-Biosciences-to-Present-Updated-Data-of-KB295-In-Ulcerative-Colitis-at-the-2022-Crohn-s-and-Colitis-Congress.html
https://www.globenewswire.com/news-release/2021/10/05/2308569/0/en/Kaleido-Biosciences-Announces-New-Clinical-and-Preclinical-Data-Supporting-Advancement-of-KB295-to-a-Phase-2-Clinical-Study-in-Mild-to-Moderate-Ulcerative-Colitis.html
https://www.globenewswire.com/news-release/2021/09/29/2305255/0/en/Kaleido-Biosciences-to-Host-Virtual-R-D-Presentation-to-Discuss-Clinical-Data-and-Pipeline-Advancement-on-October-5-2021.html
https://www.raps.org/news-and-articles/news-articles/2021/9/fda-slams-kaleido-for-failing-to-submit-ind-for-co
https://www.nutraingredients-usa.com/Article/2021/09/08/Synthetic-glycans-developer-issued-warning-over-failure-to-file-IND-in-COVID-19-trials
https://endpts.com/food-or-drug-a-flagship-backed-microbiome-players-non-ind-covid-19-trial-skirted-protocol-fda-says/
https://www.pharmacompass.com/pdf/news/kaleido-biosciences-receives-fda-warning-letter-1631095738.pdf
https://www.globenewswire.com/news-release/2021/08/06/2276389/0/en/Kaleido-Biosciences-to-Participate-in-the-41st-Annual-Canaccord-Genuity-Growth-Conference.html
https://www.globenewswire.com/news-release/2021/05/04/2222159/0/en/Kaleido-Biosciences-Reports-First-Quarter-2021-Financial-Results.html#:~:text=First%20Quarter%20Financial%20Results,the%20same%20period%20in%202020.
Market Place
Share 
